Drug profile · INN
isosorbide dinitrate
ISORDIL SUBLINGUAL
isosorbide dinitrate (ISORDIL SUBLINGUAL) is a soluble guanylate cyclase activator. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — isosorbide dinitrate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 2
- Programs
- 10
- Data quality
- 0.89
Quick answer
isosorbide dinitrate (ISORDIL SUBLINGUAL) is a soluble guanylate cyclase activator. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Soluble guanylate cyclase activator
Primary target: Soluble guanylate cyclase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
- Sublingual film containing Dexmedetomidine (BXCL501)
- Sublingual film containing dexmedetomidine (BXCL501)
- Sublingual film containing Dexmedetomidine
- sublingual nitroglycerine
- sublingual tizanidine 12 mg
- Sublingual Tizanidine HCl
- Sublingual film containing BXCL501 (Dexmedetomidine)
- Sublingual film containing Igalmi
Related & competitor drugs
Related patents
Frequently asked questions
What is isosorbide dinitrate?
isosorbide dinitrate (ISORDIL SUBLINGUAL) is a soluble guanylate cyclase activator. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for isosorbide dinitrate?
ISORDIL SUBLINGUAL is a marketed brand name for isosorbide dinitrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of isosorbide dinitrate?
isosorbide dinitrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.